Woodline Partners LP

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,571,086

+$3,337,639 QoQ

Shares Held

1,485,623

+100.2% QoQ

Ownership

1.06%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. ACRS ranks #109 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,571,086	1,485,623	+100.2%	Shares	Sole	2026-05-15
2025-12-31	$2,233,447	742,009	+335.9%	Shares	Sole	2026-02-17
2023-09-30	$1,166,075	170,230	+67.7%	Shares	Sole	2023-11-14
2023-06-30	$1,052,544	101,499	-55.1%	Shares	Sole	2023-08-14
2023-03-31	$1,829,974	226,202	-62.5%	Shares	Sole	2023-05-15
2022-12-31	$9,489,674	602,519	-13.6%	Shares	Sole	2023-02-14
2022-09-30	$10,970,890	697,007	+12.1%	Shares	Sole	2022-11-14
2022-06-30	$8,676,935	621,557	+4.5%	Shares	Sole	2022-08-15
2021-09-30	$10,705,824	594,768	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.